La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
EMVision Medical Devices Gestion
Gestion contrôle des critères 3/4
EMVision Medical Devices' CEO is Scott Kirkland, appointed in Jul 2023, has a tenure of 1.08 years. total yearly compensation is A$469.42K, comprised of 54.9% salary and 45.1% bonuses, including company stock and options. directly owns 5.01% of the company’s shares, worth A$9.24M. The average tenure of the management team and the board of directors is 2.5 years and 5.2 years respectively.
Informations clés
Scott Kirkland
Directeur général
AU$469.4k
Rémunération totale
| Pourcentage du salaire du PDG | 54.9% |
| Durée du mandat du directeur général | 1.1yrs |
| Propriété du PDG | 5.0% |
| Durée moyenne d'occupation des postes de direction | 2.5yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.2yrs |
Mises à jour récentes de la gestion
Recent updates
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21
Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$3m |
| Sep 30 2023 | n/a | n/a | -AU$4m |
| Jun 30 2023 | AU$469k | AU$258k | -AU$4m |
| Mar 31 2023 | n/a | n/a | -AU$4m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$270k | AU$245k | -AU$6m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$7m |
| Sep 30 2021 | n/a | n/a | -AU$8m |
| Jun 30 2021 | AU$262k | AU$240k | -AU$8m |
| Mar 31 2021 | n/a | n/a | -AU$7m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$224k | AU$205k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$3m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$213k | AU$150k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | AU$45k | AU$41k | -AU$2m |
Rémunération vs marché: La rémunération totale de Scott ($USD 313.07K ) est dans la moyenne des entreprises de taille similaire sur le marché Australian ($USD 296.93K ).
Rémunération et revenus: Scott's compensation has increased whilst the company is unprofitable.
PDG
Scott Kirkland
1.1yrs
Titularisation
AU$469,419
Compensation
Mr. Scott Kirkland has been an Executive Director of EMvision Medical Devices Limited since July 11, 2017 and serves as its Chief Executive Officer and Managing Director since July 01, 2023. Mr. Kirkland h...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Executive Director | 1.1yrs | AU$469.42k | 5.01% A$ 9.2m | |
| CFO & Company Secretary | 7yrs | pas de données | 1.36% A$ 2.5m | |
| Chief Technology Officer | 1.6yrs | pas de données | pas de données | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 3.7yrs | pas de données | 1.22% A$ 2.3m | |
| Head of Design | 3.5yrs | pas de données | pas de données | |
| Head of Tech Development | no data | pas de données | pas de données | |
| Head of Regulatory Affairs | 1.3yrs | pas de données | pas de données |
2.5yrs
Durée moyenne de l'emploi
Gestion expérimentée: EMV's management team is considered experienced (2.5 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Executive Director | 7.1yrs | AU$469.42k | 5.01% A$ 9.2m | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 5.2yrs | pas de données | 1.22% A$ 2.3m | |
| Ex-Officio Member | 2.4yrs | pas de données | pas de données | |
| Independent Non-Executive Director | 3.9yrs | AU$274.57k | 0.056% A$ 102.6k | |
| Non-Executive Chairman | 6.4yrs | AU$349.37k | 2.42% A$ 4.5m | |
| Non-Executive Director | 6.4yrs | AU$218.18k | 1% A$ 1.8m | |
| Independent Non-Executive Director | 6.2yrs | AU$218.18k | 0.70% A$ 1.3m | |
| Member of Clinical Advisory Board | 5.2yrs | pas de données | pas de données | |
| Member of Clinical Advisory Board | 5.2yrs | pas de données | pas de données | |
| Member of Clinical Advisory Board | 5.2yrs | pas de données | pas de données | |
| Member of Clinical Advisory Board | 5.2yrs | pas de données | pas de données | |
| Ex-Officio Member | 2.4yrs | pas de données | pas de données |
5.2yrs
Durée moyenne de l'emploi
Conseil d'administration expérimenté: EMV's board of directors are considered experienced (5.2 years average tenure).